CLEAR CELL RENAL CELL CANCER (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CANCER (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CANCER (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CANCER (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Smart Bomb' therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a two-part approach for people with advanced solid tumors that cannot be removed by surgery. First, a radioactive tracer helps doctors see the tumor on scans. Then, a therapeutic dose of radiation is given to destroy cancer cells. The goal is to find the safest a…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: ITM Oncologics GmbH • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new experimental drug called GI-101, given alone or with other cancer drugs (pembrolizumab or lenvatinib), in people with advanced solid tumors that have spread. The goal is to see if the drug is safe and can shrink or control tumors. About 317 adults with canc…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New radiation therapy shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a new drug, 177Lu-TLX250, which delivers radiation directly to kidney cancer cells that have a specific marker (CAIX). It is for adults with advanced clear cell kidney cancer that has come back or not responded to at least two prior treatments. The trial compares…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New imaging agent could sharpen cancer detection
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: NA • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 18, 2026 12:00 UTC